Large-scale testing (Phase 3)Study completedNCT00872586
What this trial is testing
Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension
Who this might be right for
Essential Hypertension
Daiichi Sankyo 304